Women's Health
What Causes Low DHEA-S in Women?
Low DHEA-S is one of the most underdiagnosed hormonal findings in women's lab work, yet it predicts fatigue, low libido, bone loss, and cognitive fog years before menopause arrives. Understanding what drives it down — and what can support your adrenal axis — is the first step toward restoring your energy and hormonal resilience.

What Causes Low DHEA-S in Women?
Low DHEA-S in women is most commonly caused by adrenal insufficiency or the natural age-related decline that begins in your mid-20s and accelerates after 40. Chronic stress, poor sleep, and certain medications can accelerate this drop significantly. The exception is women with adrenal tumors or PCOS, who may actually have elevated DHEA-S — always interpret your result in clinical context.
---
What Is DHEA-S and Why Does It Matter?
Dehydroepiandrosterone sulfate (DHEA-S) is the sulfated, storage form of DHEA — a precursor hormone produced primarily in the zona reticularis of the adrenal cortex, with a small contribution from the ovaries. Because DHEA-S is water-soluble and has a long half-life (8–12 hours), it is used clinically as the preferred marker of adrenal androgen output. Measuring DHEA-S rather than free DHEA avoids the rapid intraday fluctuations that make free DHEA harder to interpret.
DHEA-S acts as a hormonal reservoir. It converts downstream into estrogens and testosterone in peripheral tissues — including skin, bone, the brain, and adipose tissue — giving it influence over a surprisingly wide range of physiological processes:
- Bone mineral density and fracture risk
- Mood regulation and cognitive function
- Immune competence and inflammation control
- Libido and sexual satisfaction
- Insulin sensitivity and metabolic health
- Cardiovascular protection
Reference ranges vary by lab, but most place optimal DHEA-S for premenopausal women between 90–430 µg/dL and for postmenopausal women between 15–200 µg/dL. Levels below the low end of these ranges — or even at the bottom quartile — are associated with measurable declines in well-being and function. A large cross-sectional analysis of over 2,000 adults found that DHEA-S in the lowest quartile correlated with significantly higher all-cause mortality risk and poorer functional capacity in older women (Cappola et al., Journal of Clinical Endocrinology & Metabolism 2009; PMID: 19190108).
---
The Most Common Causes of Low DHEA-S in Women
1. Age-Related Adrenal Decline (Adrenopause)
DHEA-S peaks in your mid-20s and then declines at roughly 2–3% per year. By age 70–80, most people have only 10–20% of their peak DHEA-S concentration. This process — sometimes called adrenopause — is distinct from menopause but overlaps with it, compounding the hormonal shift women experience in midlife (Labrie et al., Steroids 2010; PMID: 20060008).
The mechanism is primarily a reduction in the number and activity of zona reticularis cells in the adrenal cortex over time. Unlike cortisol production, which is maintained or even increases with age, DHEA-S biosynthesis is not ACTH-compensated — meaning the adrenal gland does not upregulate output in response to lower levels. This makes age-related decline largely irreversible without direct intervention, though lifestyle factors (sleep quality, resistance training, and stress management) can slow the trajectory.
2. Chronic Psychological and Physiological Stress
The adrenal glands produce both cortisol and DHEA-S. Under sustained stress, cortisol production is prioritized via a process sometimes described as "cortisol steal" — although more accurately, chronic ACTH stimulation gradually exhausts the adrenal reserve available for DHEA-S synthesis. Studies in women with burnout syndrome show DHEA-S levels 25–40% lower than matched controls, while cortisol-to-DHEA-S ratios are elevated, indicating a shift toward a more catabolic hormonal environment (Lennartsson et al., Stress 2013; PMID: 23126254).
Sleep debt compounds this problem. Even one week of sleeping five hours per night suppresses DHEA-S output measurably, because peak DHEA-S secretion occurs during the early morning hours that are cut short by sleep restriction. Women managing high-demand careers, caregiving, or chronic illness are disproportionately exposed to both stressors simultaneously.
3. Hypothalamic-Pituitary-Adrenal (HPA) Axis Dysfunction
Secondary adrenal insufficiency — caused not by adrenal damage but by reduced ACTH signaling from the pituitary — can suppress DHEA-S selectively. This is especially relevant in women who have used oral corticosteroids (prednisone, hydrocortisone) for extended periods; exogenous cortisol suppresses ACTH, which then reduces adrenal androgen output for weeks to months after discontinuation. If you have low thyroid function, HPA axis feedback loops are further disrupted, as thyroid hormones regulate glucocorticoid receptor sensitivity.
4. Nutritional Deficiencies
DHEA synthesis requires several cofactors. The rate-limiting step in adrenal steroidogenesis is the conversion of cholesterol to pregnenolone, catalyzed by the enzyme CYP11A1 — a mitochondrial cytochrome P450 enzyme that depends on NADPH availability. Deficiencies in zinc, B5 (pantothenic acid), and vitamin C can impair adrenal enzyme function. Low zinc in women deserves particular attention, as zinc is required for the pituitary-adrenal signaling axis and for protecting adrenal cells from oxidative stress during high-cortisol states.
Caloric restriction and very low-fat diets also reduce DHEA-S. Because cholesterol is the structural precursor to all steroid hormones, chronically low LDL — a scenario explored in depth at what causes low cholesterol in women — can limit the substrate available for DHEA synthesis. This is an underappreciated mechanism in women who have aggressively restricted dietary fat.
5. Low Ferritin and Iron Deficiency
Iron is a critical cofactor in the mitochondrial electron transport chain, and adrenal steroidogenesis is an energetically expensive process. Women with low ferritin often present with low DHEA-S as a downstream consequence, not because iron directly regulates DHEA biosynthesis, but because mitochondrial energy deficiency limits adrenal output broadly. Low ferritin in women is frequently overlooked as a driver of adrenal underperformance — a serum ferritin below 30 ng/mL impairs cellular energy in tissues with high metabolic demands, including the adrenal cortex.
6. Autoimmune and Inflammatory Conditions
Autoimmune adrenalitis (the leading cause of Addison's disease) destroys the adrenal cortex progressively, with DHEA-S falling earlier than cortisol in many cases because the zona reticularis is thinner and more vulnerable. Even sub-clinical autoimmune activity — detectable via adrenal antibodies — can suppress DHEA-S output years before frank adrenal insufficiency develops.
Systemic inflammatory conditions (lupus, rheumatoid arthritis, Crohn's disease) also suppress DHEA-S via elevated pro-inflammatory cytokines (IL-6, TNF-α), which downregulate CYP17A1, the enzyme responsible for DHEA biosynthesis. Studies in women with lupus show DHEA-S levels roughly 50% below age-matched controls, and low DHEA-S in this population correlates with disease activity scores (Petri et al., Lupus 1994; PMID: 7858107).
---
Symptoms of Low DHEA-S
Symptoms are often nonspecific, which is why low DHEA-S is frequently missed until a comprehensive blood panel is ordered:
| Symptom Category | Common Presentations |
|---|---|
| Energy & Fatigue | Persistent low energy, poor exercise recovery, afternoon crashes |
| Mood & Cognition | Anxiety, low motivation, brain fog, difficulty concentrating |
| Sexual Health | Low libido, reduced genital sensitivity, vaginal dryness |
| Body Composition | Difficulty building or retaining muscle, increased abdominal fat |
| Skin & Hair | Dry skin, thinning pubic and axillary hair, reduced skin elasticity |
| Bone Health | Accelerated bone density loss, fracture risk rising in perimenopause |
| Immune Function | Frequent infections, prolonged recovery, heightened inflammation |
It is worth noting that low DHEA-S overlaps clinically with low progesterone, low ferritin, and low thyroid — which is why women often present with several of these simultaneously. If you have been told your progesterone levels are low, evaluating DHEA-S in the same panel gives a fuller picture of adrenal and ovarian hormonal output.
---
Diagnostic Interpretation: What "Low" Actually Means
Lab reference ranges for DHEA-S are broad, and many women with symptoms fall in the low-normal zone — technically within range, but at the bottom 20th percentile for their age. Clinically, the more useful metric is DHEA-S relative to your cortisol-to-DHEA-S ratio. A ratio above 10 (cortisol in µg/dL to DHEA-S in µg/dL, adjusted for lab units) suggests the adrenal axis has shifted toward a stress-catabolic state rather than an anabolic one — associated with worse metabolic and immune outcomes regardless of whether DHEA-S is technically in range.
An ACTH stimulation test can help determine whether low DHEA-S reflects primary adrenal insufficiency (adrenal glands not responding) versus secondary (insufficient pituitary ACTH signaling). Your physician should also check fasting insulin, TSH, and thyroid antibodies in the same workup, as low TSH in women can mask or compound adrenal insufficiency symptoms.
---
Lifestyle and Nutritional Strategies to Support DHEA-S
Before considering supplementation, foundational strategies have meaningful evidence:
- Prioritize sleep architecture — Targeting 7.5–9 hours with consistent wake times restores the early-morning DHEA-S secretion window. Melatonin and darkness protocols matter here, as light suppression of melatonin secondarily affects adrenal cortex rhythms.
- Resistance training 3–4× per week — Acute resistance exercise transiently raises DHEA-S, and consistent training is associated with attenuated age-related decline compared to sedentary women.
- Reduce cortisol load — Chronic caloric deficit, overtraining, and unmanaged psychological stress are the three most correctable cortisol drivers. Twelve weeks of stress-reduction practices (mindfulness-based stress reduction) raised DHEA-S by 23% relative to baseline in one controlled trial (Carlson et al., Psychosomatic Medicine 2004; PMID: 15039505).
- Adequate dietary fat and cholesterol — Steroidogenesis requires cholesterol. Women eating less than 20% of calories from fat show measurably lower DHEA-S than those in the 30–35% range.
- Correct upstream deficiencies — Iron, zinc, vitamin C, and B5 are the priority micronutrients for adrenal support. Repletion of these alone can improve DHEA-S within 60–90 days if deficiency was the driver.
---
What This Means for Your Formula
While DHEA itself is a prescription substance in some countries and not part of the Ones ingredient catalog, the adrenal axis that governs DHEA-S production can be meaningfully supported through evidence-based ingredients. Here is how Ones addresses the upstream drivers:
Ashwagandha (KSM-66, 600 mg): KSM-66 is the most studied adaptogenic extract for HPA axis regulation. An 8-week randomized controlled trial in chronically stressed adults found that 600 mg/day of KSM-66 reduced serum cortisol by 27.9% and significantly improved self-reported energy and well-being (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). By reducing the cortisol load on the adrenal glands, ashwagandha creates more capacity for DHEA-S synthesis — the "cortisol steal" mechanism in reverse.
Ones Adrenal Support (System Blend): This proprietary blend is formulated to support adrenal cortex function and HPA axis resilience. It combines adaptogenic and micronutrient ingredients targeted at women whose lab results show elevated cortisol-to-DHEA-S ratios or clinical indicators of adrenal underperformance.
Zinc (as zinc bisglycinate, 15–25 mg): Zinc is required for pituitary-adrenal signaling and protects adrenal cells from oxidative damage during high-cortisol states. Ones formulas include zinc at clinically relevant doses calibrated to the user's serum zinc level and intake gap — not a one-size-fits-all dose.
If your Ones AI analysis identifies low DHEA-S alongside elevated cortisol, disrupted ferritin, or thyroid markers, your custom formula will reflect that full picture — not just one isolated biomarker.
---
Key Takeaways
- DHEA-S declines naturally from your mid-20s onward, but chronic stress, poor sleep, nutritional gaps, and autoimmune conditions can accelerate this drop far ahead of schedule.
- Symptoms — fatigue, low libido, brain fog, muscle loss — are nonspecific and frequently attributed to other causes, making a blood panel the only reliable diagnostic step.
- The cortisol-to-DHEA-S ratio is often more clinically meaningful than DHEA-S in isolation; a high ratio indicates the adrenal axis has shifted toward a catabolic, stress-dominant state.
- Upstream drivers to correct first include iron deficiency, zinc insufficiency, caloric restriction, overtraining, and sleep debt — these can restore DHEA-S meaningfully within 60–90 days if they were the primary cause.
- Adaptogens like KSM-66 ashwagandha have RCT evidence for reducing cortisol load, which indirectly supports DHEA-S output by relieving adrenal demand.
- Always interpret DHEA-S alongside TSH, fasting insulin, ferritin, and sex hormones — it rarely falls in isolation, and treating it without addressing co-existing deficiencies produces incomplete results.